Watson Pharma Private Limited — Simvastatin Exporter Profile
Indian Pharmaceutical Exporter · #15 for Simvastatin · $1.1M export value · DGFT Verified
Watson Pharma Private Limited is the #15 Indian exporter of Simvastatin with $1.1M in export value and 33 verified shipments. Watson Pharma Private Limited holds a 0.9% market share in Simvastatin exports across 3 countries. The company exports 14 pharmaceutical products worth $63.4M across 7 therapeutic categories.
Watson Pharma Private Limited — Simvastatin Export Profile: Buyers & Destinations
Where Does Watson Pharma Private Limited Export Simvastatin?
| Country | Value | Shipments | Share |
|---|---|---|---|
| MALTA | $447.6K | 13 | 41.7% |
| BULGARIA | $341.8K | 9 | 31.8% |
| UNITED STATES | $285.2K | 11 | 26.5% |
Watson Pharma Private Limited exports Simvastatin to 3 countries. The largest destination is MALTA accounting for 41.7% of Watson Pharma Private Limited's Simvastatin shipments, followed by BULGARIA (31.8%) and UNITED STATES (26.5%). These destinations reflect Watson Pharma Private Limited's established distribution network and regulatory approvals in key markets.
Who Are the Top Buyers of Simvastatin from Watson Pharma Private Limited?
| Buyer | Country | Value | Orders |
|---|---|---|---|
| ACTAVIS LIMITED | MALTA | $447.6K | 13 |
| BALKANPHARMA DUPNITSA AD | BULGARIA | $341.8K | 9 |
| ACTAVIS LABORATORIES FL, INC. | UNITED STATES | $229.1K | 9 |
| ACTAVIS LABORATORIES FL INC | UNITED STATES | $56.1K | 2 |
Watson Pharma Private Limited supplies Simvastatin to 4 buyers globally. The largest buyer is ACTAVIS LIMITED (MALTA), followed by BALKANPHARMA DUPNITSA AD (BULGARIA) and ACTAVIS LABORATORIES FL, INC. (UNITED STATES). These buyers represent pharmaceutical distributors, hospital groups, and government procurement agencies in their respective markets.
What Is India's Total Simvastatin Export Value and How Much Does Watson Pharma Private Limited Contribute?
India exported $80.8M worth of Simvastatin through 3,854 shipments from 150 suppliers to 84 countries, serving 421 buyers globally. Watson Pharma Private Limited contributes $1.1M to this total, accounting for 0.9% of India's Simvastatin exports. Watson Pharma Private Limited ships Simvastatin to 3 countries through 4 buyers.
What Is the Average Shipment Value for Watson Pharma Private Limited's Simvastatin Exports?
Watson Pharma Private Limited's average Simvastatin shipment value is $32.7K per consignment, based on 33 shipments totaling $1.1M. The largest destination is MALTA (41.7% of Watson Pharma Private Limited's Simvastatin exports).
How Does Watson Pharma Private Limited Compare to Other Indian Simvastatin Exporters?
Watson Pharma Private Limited ranks #15 among 150 Indian Simvastatin exporters with a 0.9% market share. The top 3 exporters are LUPIN LIMITED ($20.8M), MYLAN LABORATORIES LIMITED ($13.3M), SUN PHARMACEUTICAL INDUSTRIES LIMITED ($10.4M). Watson Pharma Private Limited processed 33 shipments to 3 destination countries.
What Simvastatin Formulations Does Watson Pharma Private Limited Export?
| Product Description / Formulation | Value | Shipments |
|---|---|---|
| EZETIMIBE AND SIMVASTATIN TABLETS 10MG/2 | $364.3K | 12 |
| EZETIMIBE AND SIMVASTATIN TABLETS 10MG/4 | $253.7K | 6 |
| EZETIMIBE AND SIMVASTATIN TABLET 10MG/40 | $81.6K | 3 |
| EZETIMIBE AND SIMVASTATIN TABLET 10MG/20 | $77.6K | 2 |
| EZETIMIBE AND SIMVASTATIN TABLET 10MG/10 | $54.3K | 3 |
| EZETIMIBE AND SIMVASTATIN TABLETS 10MG/1 | $50.0K | 1 |
| EZETIMIBE AND SIMVASTATIN TABLETS 10MG 40MG 2 5KG Batch No 1122501123 Mfg Date 01 11 2022 Expiry Date 31 10 2024 Qu | $40.6K | 1 |
| EZETIMIBE AND SIMVASTATIN TABLETS 10MG 40MG 2 5KG Batch No 1122501141 Mfg Date 10 11 2022 Expiry Date 31 10 2024 Qu | $40.6K | 1 |
| EZETIMIBE AND SIMVASTATIN TABLETS 10MG 40MG 2 5KG Batch No 1122501129 Mfg Date 01 11 2022 Expiry Date 31 10 2024 Qu | $40.2K | 1 |
| EZETIMIBE AND SIMVASTATIN TABLET 10MG/20MG Batch No.1123501159 MANUFACTURING Date.12.10.2023 Expiry Date.30.09.2025 Quantity | $31.7K | 1 |
Watson Pharma Private Limited exports 12 distinct Simvastatin formulations including tablets, capsules, syrups, and combination drugs. The top formulation is EZETIMIBE AND SIMVASTATIN TABLETS 10MG/2 with 12 shipments worth $364.3K. Notable combination products include fixed-dose combinations with other active ingredients, meeting diverse global regulatory requirements.
Regulatory Requirements: Exporting Simvastatin to Key Markets
What Watson Pharma Private Limited must comply with to export Simvastatin to its top destination countries
United States — FDA
Approval Process
ANDA (Abbreviated New Drug Application) for generics. Indian manufacturing site must pass FDA pre-approval inspection. Drug Master File (DMF) required for APIs.
Timeline: 10–18 months for ANDA approval
GMP & Export Requirements
FDA cGMP compliance (21 CFR 210/211); facility inspection by FDA
Drug Listing with FDA; Export Certificate from CDSCO India; Import Alert screening via FDA PREDICT system
Note: Subject to FDA Import Alerts. Open Form 483 observations can block all exports from a facility.
Regulatory information is provided for general reference based on publicly available guidelines. Requirements vary by formulation, dosage form, and therapeutic classification. Exporters should consult qualified regulatory affairs professionals for case-specific guidance.
How Does Watson Pharma Private Limited Compare to Nearest Simvastatin Exporters?
Exporters ranked immediately above and below #15 by export value
| # | Supplier | Export Value | Shipments | Countries | Avg/Shipment |
|---|---|---|---|---|---|
| 14 | CIPLA LIMITED | $1.6M | 131 | 4 | $12.3K |
| 11 | QUALIGENS PHARMA PRIVATE LIMITED | $1.4M | 27 | 1 | $50.0K |
| 15 | WATSON PHARMA PRIVATE LIMITED ★ | $1.1M | 33 | 3 | $32.7K |
| 8 | FREDUN PHARMACEUTICALS LTD | $950.0K | 19 | 1 | $50.0K |
Watson Pharma Private Limited ranks #15 among 150 Indian Simvastatin exporters. Average shipment value of $32.7K compared to the market average of $538.9K. The closest competitors by value are CIPLA LIMITED and QUALIGENS PHARMA PRIVATE LIMITED.
Which Indian Ports Ship Simvastatin Exports?
| Port | Shipments | % Share |
|---|---|---|
| NHAVA SHEVA SEA (INNSA1) | 422 | 10.9% |
| SAHAR AIR CARGO ACC (INBOM4) | 301 | 7.8% |
| SAHAR AIR | 240 | 6.2% |
| JNPT/ NHAVA SHEVA SEA | 228 | 5.9% |
| DELHI AIR | 216 | 5.6% |
| DELHI AIR CARGO ACC (INDEL4) | 202 | 5.2% |
| VIZAG SEA | 177 | 4.6% |
| MUNDRA SEA | 150 | 3.9% |
What Other Cardiovascular Products Does Watson Pharma Private Limited Export?
Watson Pharma Private Limited also exports these cardiovascular products. Each links to the detailed product page.
Geopolitical & Trade Policy Impact on Watson Pharma Private Limited's Simvastatin Exports
The current geopolitical landscape presents both challenges and opportunities for Indian pharmaceutical exporters like Watson Pharma. The Israel-Iran conflict has disrupted key shipping routes in the Red Sea, leading to increased freight costs and extended transit times. These disruptions have particularly impacted time-sensitive pharmaceutical shipments, necessitating strategic adjustments in logistics and inventory management. (pharmaceuticalcommerce.com)
Conversely, the US-China trade tensions have opened avenues for Indian exporters to strengthen their foothold in the US market. India's pharmaceutical exports to the US surged by 20.4% to approximately $10.5 billion in FY25, despite challenges such as pricing pressures and regulatory scrutiny. (economictimes.indiatimes.com) This growth underscores the potential for companies like Watson Pharma to expand their presence in the US market.
The recent India-European Union Free Trade Agreement (FTA), signed in January 2026, is poised to eliminate tariffs on pharmaceuticals, enhancing market access for Indian exporters. This development offers Watson Pharma an opportunity to increase its exports to the EU, provided it meets the stringent regulatory standards set by the European Medicines Agency (EMA). (en.wikipedia.org)
Watson Pharma Private Limited — Regulatory Compliance & Quality Standards
Compliance with international regulatory standards is paramount for Indian pharmaceutical exporters. India has made significant strides in this area, with the number of FDA-approved manufacturing sites surpassing those in the US as of 2024. Instances of non-compliance have also decreased, reflecting improved adherence to quality standards. (business-standard.com) For Watson Pharma, maintaining and enhancing compliance with FDA, WHO GMP, and EMA standards is crucial to sustaining and expanding its export markets.
The evolving regulatory environment, including the EU's Falsified Medicines Directive, necessitates robust traceability and anti-counterfeiting measures. Watson Pharma must invest in advanced serialization and tracking systems to ensure compliance and maintain trust with international partners.
About Watson Pharma Private Limited
Watson Pharma Private Limited exports 14 products worth $63.4M. Beyond Simvastatin, top products include Gabapentin, Alprazolam, Hydrochlorothiazide, Prednisone, Dapagliflozin. View the complete Watson Pharma Private Limited profile for full portfolio analysis.
Market Intelligence
Latest developments and market context
Detailed market intelligence for Simvastatin — including regulatory updates, trade policy changes, and competitive landscape analysis — will be available in an upcoming update. This section will feature AI-researched insights from verified industry sources, government notifications, and market reports.
Official References & Regulatory Resources
- CDSCO India
- Pharmexcil
- IBEF — India Pharma Industry
- Ministry of Commerce — Pharma Exports
- India Trade Statistics (DGFT)
Verify manufacturer licensing and export certifications with the official agencies above.
Research Methodology & Data Transparency
Suresh Sormare
Verified AuthorPharmaceutical Export-Import Analyst & Trade Intelligence Expert
Suresh Sormare is a pharmaceutical export-import analyst with deep expertise in Indian Customs (DGFT) data, HS code classification, and global pharmaceutical supply chains. His analysis covers 10M+ shipment records across 150+ countries and is used by manufacturers, procurement agencies, and trade consultants worldwide. Suresh specializes in identifying verified suppliers and buyers from customs records, mapping bilateral pharmaceutical trade corridors, analyzing tariff structures and regulatory frameworks across 170+ destination markets, and benchmarking competitive positioning for finished pharmaceutical formulations. His methodology combines granular customs transaction data with regulatory intelligence from FDA, EMA, WHO, CDSCO, and 40+ national drug authorities to deliver actionable trade insights for the pharmaceutical formulations sector.
linkedin.com/in/sureshsormarePrimary Data Source
All trade data is sourced from Indian Customs (DGFT) official shipping bill records — the authoritative government database for India's pharmaceutical trade. Each verified record contains exporter name, consignee (buyer) name, detailed product description, quantity, declared FOB value (USD), port of loading, destination country, and shipment date.
Analysis Methodology
- 1.Product Matching: Simvastatin shipments identified using fuzzy matching on DGFT product description fields, validated against Indian Pharmacopoeia nomenclature.
- 2.Supplier Identification: Watson Pharma Private Limited matched across shipments using name normalization, accounting for company name formatting variations.
- 3.Statistical Normalization: Shipment values are statistically normalized to ensure accurate market share representation. This removes the impact of unusually large one-off transactions that could distort company rankings.
- 4.Verified Records: This page is backed by 33 individual customs records matching Watson Pharma Private Limited exporting Simvastatin, covering 12 formulations to 3 countries via 4 buyers.
Government-Sourced Data
Official DGFT customs records
Transparent Methodology
Calculations fully disclosed above
Global Coverage
Exports to 84+ countries, 421+ buyers
Expert-Reviewed
Analyzed by pharmaceutical trade specialists
Get Simvastatin Export Data from Watson Pharma Private Limited
Access shipment-level details, pricing data, buyer connections, and competitive analysis for Watson Pharma Private Limited's Simvastatin exports. TransData Nexus provides verified Indian Customs (DGFT) data trusted by pharmaceutical trade professionals worldwide.
Watson Pharma Private Limited
Full Company Profile →
14 products · $63.4M total trade · 7 categories
Simvastatin Stats
Company Overview
Top Products by Watson Pharma Private Limited
Related Analysis
Need Detailed Export Data?
Access shipment-level records, pricing trends, and buyer contacts for Watson Pharma Private Limited.
Request DemoView Pricing →Data Source
Trade data sourced from Indian Customs (DGFT) export shipment records. Values represent FOB export value in USD. Market share calculated relative to total Indian pharmaceutical exports for Simvastatin. For current shipment-level data, contact TransData Nexus.